ArticleBMC health services research2025
Single-center retrospective analysis of the impact of rurality on glioblastoma care in Vermont.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glioblastoma survival in rural America: a 10-year experience from a quaternary care center.Journal of neuro-oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeUS residents of rural counties have a higher cancer-associated mortality than their urban and suburban counterparts. The impact of rurality is under-studied in glioblastoma. The purpose of this study is to determine if there are differences in clinical presentation, treatment patterns and outcomes in patients with newly diagnosed glioblastoma from urban and rural counties presenting to a single tertiary medical center in Vermont.
methodsIn this IRB-approved retrospective cohort study, adult patients newly diagnosed with glioblastoma from 2017 to 2021 were consecutively reviewed. Urban vs. rural county of residence was determined by US Department of Agriculture Rural-Urban Continuum Codes (1–3 = urban; 4–9 = rural). Correlates were assessed using Chi-Square test on SPSS (p-value < 0.05).
results119 patients, 51 urban and 68 rural, of similar age, KPS, gender, ethnicity, and sex treated with the University of Vermont Medical Center (UVMMC) were included in the analysis. Time between symptom onset and neurosurgery did not significantly differ (median 14 days for rural patients and 15 for urban patients). Percent receiving gross total resection was similar (45% rural vs. 47% urban). 81% of rural patients vs. 82% urban received radiation and 78% rural and 80% urban received adjuvant temozolomide. Median progression free survival was 6.4 months for rural patients vs. 4.3 months for urban (p > 0.05), and overall survival was 11.6 vs. 8.3 months, respectively, (p > 0.05).
conclusionUrban and rural patients with glioblastoma at UVMMC had similar presentation, treatment, and outcomes. We hypothesize that access to a tertiary hospital centrally located in a rural catchment area with access to multidisciplinary neuro-oncologic management may help mitigate the disparities rural patients face when accessing cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.